The efficacy of H. pylori eradication therapy with sitafloxacin-metronidazole-vonaprazan regime
Not Applicable
Recruiting
- Conditions
- Helicobacter pylori infectionA498
- Registration Number
- JPRN-jRCTs031180412
- Lead Sponsor
- Hirata Kenro
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
H. pylori-positve patients after the 2nd line H. pylori eradication therapy or penicillin-allergic patients
Exclusion Criteria
1. Patients with allergy for quinolones
2. Patients with allergy for PPIs
3. Patients with severe liver injury and/or severe renal damage
4. Pregnancy or possible pregnancy
5. Patients who were recognized as inappropriate for entry
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The efficacy of eradication treatment
- Secondary Outcome Measures
Name Time Method 1) adverse events <br>2) MIC of STFX,MNZ, gyrA mutation